New Year Focus: Devices, Policy, and Health Equity

This January 2022 issue opens with AVF's plan for an in-person VENOUS2022 with COVID-19 safety measures and a virtual option, then turns to New Year resolutions from members. Contributors weigh new DVT intervention devices against cost effectiveness, argue for keeping legacy stents such as the Wallstent and Gianturco Z-stent in the toolkit, and describe Boston Scientific's commitment to the HI-PEITHO trial and diversity in clinical trial enrollment. The issue also reports a coverage policy win with Anthem Blue Cross California and a new telemedicine billing modifier.